Headquartered in Westchester, IL·Fiscal year ends December·NYSE: INGR·ingredion.com
About Ingredion
Ingredion Incorporated (NYSE: INGR) is a global ingredient solutions provider serving customers in more than 120 countries across the food, beverage, animal nutrition, brewing, and industrial markets. The company transforms grains, fruits, vegetables, and other plant-based materials into value-added ingredient solutions, including starches, sweeteners, clean-label texturizers, plant-based proteins, stevia and other sugar reduction ingredients, and specialty ingredients for healthful formulations. With 2025 annual net sales of approximately $7.2 billion and more than 11,000 employees, Ingredion operates innovation centers (Ingredion Idea Labs) around the world and co-creates solutions with customers. The company reports through three main segments — Texture & Healthful Solutions, Food & Industrial Ingredients–LATAM, and Food & Industrial Ingredients–U.S./Canada — along with an All Other category that includes its Pakistan sweetener and starch business, PureCircle sugar reduction business, and Protein Fortification business. Ingredion has a pending all-cash acquisition of Tate & Lyle at 595 pence per share, which was approved by Tate & Lyle shareholders on July 28, 2026, and is expected to significantly expand the company's global ingredient solutions capabilities. Updated
Jim Cramer called packaged food stocks 'so hated' right now, but the data behind the sentiment tells a more complicated story that could catch contrarian buyers off guard.
Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday, after the drubbing they took on Friday, and it looks the same way today. While it…
Ingredion Incorporated (NYSE: INGR) is a global ingredient solutions provider serving customers in more than 120 countries across the food, beverage, animal nutrition, brewing, and industrial markets.
What is the INGR stock price target?
24/7 Wall St.'s 12-month price target for INGR is $113.87, rated Buy. The Wall Street consensus target is $119.50. INGR price prediction →